Neuro-ophthalmologists concerned over Ophthalmic complications in patients on antidiabetic GLP-1 medications: JAMA Dr. Kamal Kant Kohli14 Feb 2025 8:15 PM IST A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a direct causal link...
New Research Highlights Effective Stem Cell Treatment for Inflammatory Eye Diseases Dr. Bhumika Maikhuri13 Feb 2025 8:15 AM ISTIn a new study, researchers have proposed a novel therapy for ocular Graft-versus-host disease involving Mesenchymal stromal cells (MSCs). The team...
Study Highlights Early Warning Signs for Worse Outcomes in Idiopathic Facial Palsy Medha Baranwal11 Feb 2025 9:00 PM ISTSpain: A new study has highlighted key early prognostic markers for idiopathic facial palsy, suggesting that retroauricular pain and white blood cell...
Sanofi secures approval in India for chronic graft-versus-host disease drug Rezurock Ruchika Sharma11 Feb 2025 4:30 PM ISTSanofi Healthcare India Pvt. Limited has announced receipt of marketing authorization for Rezurock (Belumosudil Tablets) in India....
Individuals with Primary Open-Angle Glaucoma may have Cognitive Impairment, reveals research Jacinthlyn Sylvia7 Feb 2025 9:00 PM ISTA recent study published in the Journal of Glaucoma revealed that individuals with Primary Open Angle Glaucoma (POAG) show cognitive impairments...
Use of speculum not solely responsible for postoperative ptosis: Study Jacinthlyn Sylvia6 Feb 2025 9:15 PM ISTA recent study explored the potential relationship between the use of speculums during phacoemulsification surgery and the development of...
Use of Semaglutide and tirzepatide use linked to ophthalmic complications, finds study Jacinthlyn Sylvia5 Feb 2025 9:00 PM ISTAlmost 2% of the U.S. population received prescriptions for the weight-loss and diabetes drugs semaglutide and tirzepatide in 2023. These medications,...
FDA approves ranibizumab for treating diabetic macular edema Dr. Kamal Kant Kohli5 Feb 2025 8:30 PM ISTThe U.S. Food and Drug Administration (FDA) has approved ranibizumab injection (Susvimo, 100 mg/mL; Genentech) for the treatment of diabetic macular...
Birth weight not associated with risk of cataract or pseudophakia: Study Jacinthlyn Sylvia3 Feb 2025 8:45 PM ISTA recent study published in the Clinical Ophthalmology journal found the potential connection between birth weight (BW) and the occurrence of...
Genetic Study Links Anterior Uveitis to Autoimmune Diseases Dr. Kamal Kant Kohli31 Jan 2025 8:30 PM ISTAn international study led by the University of Oulu and Oulu University Hospital has identified six genetic regions associated with inflammation of...
Younger Age at Cataract Surgery Increases Glaucoma Risk; Glaucoma Valve Implantation Outperforms Trabeculectomy, Study Finds Medha Baranwal29 Jan 2025 8:30 PM ISTChina: Recent findings published in International Ophthalmology highlight key factors associated with the onset of glaucoma-related adverse events...
GSK Shingrix new prefilled syringe presentation accepted for review by EMA Ruchika Sharma28 Jan 2025 10:15 AM ISTLondon: GSK plc has announced that the European Medicines Agency (EMA) has accepted for review the regulatory application of a prefilled syringe...
